Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

M A Kutzler,K A Kraynyak,S J Nagle,R M Parkinson,D Zharikova,M Chattergoon,H Maguire,K Muthumani,K Ugen,D B Weiner

DOI: https://doi.org/10.1038/gt.2009.112

2009-10-22

Gene Therapy

Abstract:A hurdle facing DNA vaccine development is the ability to generate strong immune responses systemically and at local immune sites. We report a novel systemically administered DNA vaccination strategy using intramuscular codelivery of CCL27 or CCL28, which elicited elevated peripheral IFN-γ and antigen-specific IgG while driving antigen-specific T-cell secretion of cytokine and antibody production in the gut-associated lymphoid tissue and lung. This strategy resulted in induction of long-lived antibody responses that neutralized influenza A/PR8/34 and protected mice from morbidity and mortality associated with a lethal intranasal viral challenge. This is the first example of the use of CCL27 and CCL28 chemokines as adjuvants to influence a DNA vaccine strategy, suggesting further examination of this approach for manipulation of vaccine-induced immunity impacting both quality and phenotype of responses.

genetics & heredity,biochemistry & molecular biology,medicine, research & experimental,biotechnology & applied microbiology